{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:06:21Z","timestamp":1789581981761,"version":"build-2803163510"},"update-to":[{"DOI":"10.1371\/journal.ppat.1014566","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000}}],"reference-count":65,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["RO1EY26944"],"award-info":[{"award-number":["RO1EY26944"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["RO1EY029160"],"award-info":[{"award-number":["RO1EY029160"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["RO1EY033574"],"award-info":[{"award-number":["RO1EY033574"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>Herpes simplex virus 1 (HSV\u20111) establishes infection through coordinated interactions of multiple viral glycoproteins with host cell receptors. Interactions between the viral glycoprotein D (gD) and the immunomodulatory cellular receptor HVEM (herpesvirus entry mediator) critically influence HSV\u20111 latency and reactivation by regulating both receptor engagement and immunomodulatory signaling in the corneal epithelium, immune cells, and neurons. The underlying mechanisms of these phenotypes remain poorly understood because no tools selectively block their interaction. To dissect the contributions of individual amino acids (aa) to HVEM binding, we co\u2011immunoprecipitated wild\u2011type (WT) and mutant (Q27P and Q27A\u2011L28A\u2011T29A) forms of gD that disrupt gD binding to HVEM. We found that gD aa Q27-T29 were critical for HVEM binding, with the triple mutant showing greater disruption of HVEM binding than the Q27P single mutation, as assessed by co-immunoprecipitation and immunostaining. To map gD binding to HVEM and assess functional relevance, we constructed two recombinant viruses: a single-amino-acid (aa) gD mutation (v27 virus) and a triple-aa mutation in gD (v27-29 virus). Replication of both mutant viruses was comparable to that of the WT virus in four mammalian cell lines, except in Neuro2a cells. However, using confocal microscopy, HVEM protein expression was reduced in v27-29-infected Neuro2a cells, with no gD colocalization observed. Although Neuro2a cells infected with the single gD v27 mutant also showed less HVEM-gD colocalization than Neuro2a cells infected with WT virus, gD protein levels were not affected. RT\u2011PCR analysis of Neuro2a cells infected with single and triple gD mutants showed significantly less expression of viral glycoproteins (gB, gC, gD), host receptors (HVEM, nectin\u20111, 3\u2011O\u2011sulfated heparan sulfate), and HVEM ligands (BTLA, LIGHT, Lt\u03b1, CD160), with the most pronounced effects observed for the triple v27\u201129 mutant virus. Together, these results show that aa Q27-T29, rather than aa Q27 alone, are essential to completely block gD binding to HVEM and, consequently, affect overall receptor homeostasis.<\/jats:p>","DOI":"10.1371\/journal.ppat.1014566","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:56:45Z","timestamp":1788890205000},"page":"e1014566","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Complete disruption of gD binding to HVEM alters virus replication and host receptor homeostasis"],"prefix":"10.1371","volume":"22","author":[{"given":"Deepak","family":"Arya","sequence":"first","affiliation":[{"name":"Cedars-Sinai Health Sciences University, Cedars-Sinai Medical Center","place":["Los Angeles, California, United States of America"],"department":["Center for Neurobiology and Vaccine Development, Ophthalmology Research, Department of Surgery"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kati","family":"Tormanen","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Health Sciences University, Cedars-Sinai Medical Center","place":["Los Angeles, California, United States of America"],"department":["Center for Neurobiology and Vaccine Development, Ophthalmology Research, Department of Surgery"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay J.","family":"Oh","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Health Sciences University, Cedars-Sinai Medical Center","place":["Los Angeles, California, United States of America"],"department":["Center for Neurobiology and Vaccine Development, Ophthalmology Research, Department of Surgery"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohui","family":"Wang","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Health Sciences University, Cedars-Sinai Medical Center","place":["Los Angeles, California, United States of America"],"department":["Center for Neurobiology and Vaccine Development, Ophthalmology Research, Department of Surgery"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3291-1995","authenticated-orcid":true,"given":"Homayon","family":"Ghiasi","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Health Sciences University, Cedars-Sinai Medical Center","place":["Los Angeles, California, United States of America"],"department":["Center for Neurobiology and Vaccine Development, Ophthalmology Research, Department of Surgery"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"issue":"3","key":"ppat.1014566.ref001","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1128\/mr.53.3.318-332.1989","article-title":"Human herpesviruses: a consideration of the latent state","volume":"53","author":"JG Stevens","year":"1989","journal-title":"Microbiol Rev"},{"issue":"2","key":"ppat.1014566.ref002","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1006\/mpat.1993.1059","article-title":"Viral, neuronal and immune factors which may influence herpes simplex virus (HSV) latency and reactivation","volume":"15","author":"NW Fraser","year":"1993","journal-title":"Microb Pathog"},{"key":"ppat.1014566.ref003","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-1-4684-5853-4_21","article-title":"Pathogenesis and latency of herpes simplex virus type 1 (HSV-1): an ophthalmologist\u2019s view of the eye as a model for the study of the virus-host relationship","volume":"278","author":"YJ Gordon","year":"1990","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"ppat.1014566.ref004","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0738-081X(84)90066-X","article-title":"Ocular herpes simplex virus infections","volume":"2","author":"CR Dawson","year":"1984","journal-title":"Clin Dermatol"},{"issue":"1","key":"ppat.1014566.ref005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00003226-200101000-00001","article-title":"Herpes simplex virus epidemiology and ocular importance","volume":"20","author":"TJ Liesegang","year":"2001","journal-title":"Cornea"},{"issue":"5","key":"ppat.1014566.ref006","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1462-5822.2004.00389.x","article-title":"Herpes simplex virus: receptors and ligands for cell entry","volume":"6","author":"PG Spear","year":"2004","journal-title":"Cell Microbiol"},{"issue":"1","key":"ppat.1014566.ref007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.2000.0529","article-title":"Three classes of cell surface receptors for alphaherpesvirus entry","volume":"275","author":"PG Spear","year":"2000","journal-title":"Virology"},{"issue":"11","key":"ppat.1014566.ref008","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1056\/NEJM198603133141105","article-title":"Infections with herpes simplex viruses (1)","volume":"314","author":"L Corey","year":"1986","journal-title":"N Engl J Med"},{"issue":"1","key":"ppat.1014566.ref009","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1001\/archopht.121.1.108","article-title":"Prevention of herpes simplex virus eye disease: a cost-effectiveness analysis","volume":"121","author":"DR Lairson","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"ppat.1014566.ref010","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1136\/bjo.80.11.969","article-title":"Risk factors for herpes simplex virus epithelial keratitis recurring during treatment of stromal keratitis or iridocyclitis. Herpetic Eye Disease Study Group","volume":"80","author":"KR Wilhelmus","year":"1996","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"ppat.1014566.ref011","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1128\/jvi.61.12.3820-3826.1987","article-title":"Detection of latency-related viral RNAs in trigeminal ganglia of rabbits latently infected with herpes simplex virus type 1","volume":"61","author":"DL Rock","year":"1987","journal-title":"J Virol"},{"key":"ppat.1014566.ref012","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jneuroim.2017.03.002","article-title":"HSV1 latent transcription and non-coding RNA: a critical retrospective","volume":"308","author":"D Phelan","year":"2017","journal-title":"J Neuroimmunol"},{"issue":"3","key":"ppat.1014566.ref013","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1128\/jvi.17.3.991-1008.1976","article-title":"Membrane proteins specified by herpes simplex viruses. I. Identification of four glycoprotein precursors and their products in type 1-infected cells","volume":"17","author":"PG Spear","year":"1976","journal-title":"J Virol"},{"key":"ppat.1014566.ref014","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1099\/0022-1317-68-3-715","article-title":"Herpes simplex virus glycoproteins associated with different morphological entities projecting from the virion envelope","author":"LM Stannard","year":"1987","journal-title":"J Gen Virol"},{"issue":"2","key":"ppat.1014566.ref015","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1167\/iovs.03-0828","article-title":"Improved protection from primary ocular HSV-1 infection and establishment of latency using multigenic DNA vaccines","volume":"45","author":"Y Osorio","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"ppat.1014566.ref016","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1128\/jvi.62.5.1486-1494.1988","article-title":"A herpes simplex virus mutant in which glycoprotein D sequences are replaced by beta-galactosidase sequences binds to but is unable to penetrate into cells","volume":"62","author":"MW Ligas","year":"1988","journal-title":"J Virol"},{"issue":"12","key":"ppat.1014566.ref017","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.1128\/jvi.62.12.4605-4612.1988","article-title":"Herpes simplex viruses lacking glycoprotein D are unable to inhibit virus penetration: quantitative evidence for virus-specific cell surface receptors","volume":"62","author":"DC Johnson","year":"1988","journal-title":"J Virol"},{"issue":"1","key":"ppat.1014566.ref018","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0042-6822(81)90097-0","article-title":"A virion-associated glycoprotein essential for infectivity of herpes simplex virus type 1","volume":"115","author":"SP Little","year":"1981","journal-title":"Virology"},{"key":"ppat.1014566.ref019","article-title":"Development of a herpes simplex virus subunit glycoprotein vaccine for prophylactic and therapeutic use","author":"RL Burke","year":"1991","journal-title":"Rev Infect Dis"},{"key":"ppat.1014566.ref020","first-page":"137","article-title":"Contemporary approaches to vaccination against herpes simplex virus","volume":"179","author":"RL Burke","year":"1992","journal-title":"Curr Top Microbiol Immunol"},{"issue":"1","key":"ppat.1014566.ref021","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0042-6822(91)90766-5","article-title":"Cell surface expression of herpes simplex virus type 1 glycoprotein H in recombinant baculovirus-infected cells","volume":"185","author":"H Ghiasi","year":"1991","journal-title":"Virology"},{"issue":"5369","key":"ppat.1014566.ref022","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1126\/science.280.5369.1618","article-title":"Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor","volume":"280","author":"RJ Geraghty","year":"1998","journal-title":"Science"},{"issue":"1","key":"ppat.1014566.ref023","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0092-8674(00)80058-6","article-title":"A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry","volume":"99","author":"D Shukla","year":"1999","journal-title":"Cell"},{"issue":"14","key":"ppat.1014566.ref024","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.1128\/JVI.77.14.8127-8140.2003","article-title":"Structure-based mutagenesis of herpes simplex virus glycoprotein D defines three critical regions at the gD-HveA\/HVEM binding interface","volume":"77","author":"SA Connolly","year":"2003","journal-title":"J Virol"},{"issue":"17","key":"ppat.1014566.ref025","doi-asserted-by":"crossref","first-page":"9221","DOI":"10.1128\/JVI.77.17.9221-9231.2003","article-title":"Mutations in the N termini of herpes simplex virus type 1 and 2 gDs alter functional interactions with the entry\/fusion receptors HVEM, nectin-2, and 3-O-sulfated heparan sulfate but not with nectin-1","volume":"77","author":"M Yoon","year":"2003","journal-title":"J Virol"},{"issue":"3","key":"ppat.1014566.ref026","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0092-8674(00)81363-X","article-title":"Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF\/NGF receptor family","volume":"87","author":"RI Montgomery","year":"1996","journal-title":"Cell"},{"issue":"47","key":"ppat.1014566.ref027","doi-asserted-by":"crossref","first-page":"39553","DOI":"10.1074\/jbc.M507629200","article-title":"Attenuating lymphocyte activity: the crystal structure of the BTLA-HVEM complex","volume":"280","author":"DM Compaan","year":"2005","journal-title":"J Biol Chem"},{"issue":"4","key":"ppat.1014566.ref028","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1128\/JVI.02467-13","article-title":"Regulatory interactions between herpesvirus entry mediator (TNFRSF14) and latency associated transcript (LAT) during HSV-1 latency","volume":"88","author":"SJ Allen","year":"2014","journal-title":"J Virol"},{"issue":"16","key":"ppat.1014566.ref029","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00700-20","article-title":"Restoring herpesvirus entry mediator (HVEM) immune function in HVEM(-\/-) mice rescues herpes simplex virus 1 latency and reactivation independently of binding to glycoprotein D","volume":"94","author":"K Tormanen","year":"2020","journal-title":"J Virol"},{"issue":"4","key":"ppat.1014566.ref030","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1084\/jem.20101562","article-title":"Herpesvirus entry mediator (TNFRSF14) regulates the persistence of T helper memory cell populations","volume":"208","author":"P Soroosh","year":"2011","journal-title":"J Exp Med"},{"issue":"1","key":"ppat.1014566.ref031","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1600-065X.2011.01064.x","article-title":"The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation","volume":"244","author":"MW Steinberg","year":"2011","journal-title":"Immunol Rev"},{"issue":"1","key":"ppat.1014566.ref032","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.2011.01065.x","article-title":"The TNF receptor super family in immune regulation","volume":"244","author":"CF Ware","year":"2011","journal-title":"Immunol Rev"},{"issue":"12","key":"ppat.1014566.ref033","article-title":"HVEM structures and mutants reveal distinct functions of binding to LIGHT and BTLA\/CD160","volume":"218","author":"W Liu","year":"2021","journal-title":"J Exp Med"},{"issue":"9","key":"ppat.1014566.ref034","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nri1917","article-title":"Balancing co-stimulation and inhibition with BTLA and HVEM","volume":"6","author":"KM Murphy","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"24","key":"ppat.1014566.ref035","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01451-18","article-title":"Herpes simplex virus 1 latency and the kinetics of reactivation are regulated by a complex network of interactions between the herpesvirus entry mediator, its ligands (gD, BTLA, LIGHT, and CD160), and the latency-associated transcript","volume":"92","author":"S Wang","year":"2018","journal-title":"J Virol"},{"issue":"16","key":"ppat.1014566.ref036","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00707-19","article-title":"The absence of lymphotoxin-\u03b1, a herpesvirus entry mediator (HVEM) ligand, affects herpes simplex virus 1 infection in vivo differently than the absence of other HVEM cellular ligands","volume":"93","author":"S Wang","year":"2019","journal-title":"J Virol"},{"issue":"1","key":"ppat.1014566.ref037","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/viro.1994.1098","article-title":"Single amino acid substitutions in gD of herpes simplex virus 1 confer resistance to gD-mediated interference and cause cell-type-dependent alterations in infectivity","volume":"199","author":"HJ Dean","year":"1994","journal-title":"Virology"},{"issue":"12","key":"ppat.1014566.ref038","doi-asserted-by":"crossref","first-page":"8045","DOI":"10.1128\/jvi.68.12.8045-8055.1994","article-title":"The latency-associated transcript gene of herpes simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation of HSV-1 from latency","volume":"68","author":"GC Perng","year":"1994","journal-title":"J Virol"},{"issue":"7","key":"ppat.1014566.ref039","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00054-22","article-title":"Small Noncoding RNA (sncRNA1) within the latency-associated transcript modulates herpes simplex virus 1 virulence and the host immune response during acute but not latent infection","volume":"96","author":"K Tormanen","year":"2022","journal-title":"J Virol"},{"issue":"10","key":"ppat.1014566.ref040","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01454-24","article-title":"A novel GFP-based strategy to quantitate cellular spatial associations in HSV-1 viral pathogenesis","volume":"15","author":"D Arya","year":"2024","journal-title":"mBio"},{"issue":"6","key":"ppat.1014566.ref041","article-title":"The anti-apoptotic function of HSV-1 LAT in neuronal cell cultures but not its function during reactivation correlates with expression of two small non-coding RNAs, sncRNA1&2","volume":"20","author":"JJ Oh","year":"2024","journal-title":"PLoS Pathog"},{"issue":"22","key":"ppat.1014566.ref042","doi-asserted-by":"crossref","first-page":"11646","DOI":"10.1128\/JVI.01550-10","article-title":"Herpes simplex virus glycoprotein D interferes with binding of herpesvirus entry mediator to its ligands through downregulation and direct competition","volume":"84","author":"KM Stiles","year":"2010","journal-title":"J Virol"},{"issue":"1","key":"ppat.1014566.ref043","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/ni1144","article-title":"B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator","volume":"6","author":"JR Sedy","year":"2005","journal-title":"Nat Immunol"},{"issue":"2","key":"ppat.1014566.ref044","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ni1554","article-title":"CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator","volume":"9","author":"G Cai","year":"2008","journal-title":"Nat Immunol"},{"key":"ppat.1014566.ref045","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1099\/0022-1317-71-10-2361","article-title":"Evolutionary relationships of virion glycoprotein genes in the S regions of alphaherpesvirus genomes","author":"DJ McGeoch","year":"1990","journal-title":"J Gen Virol"},{"issue":"2","key":"ppat.1014566.ref046","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.virol.2012.08.043","article-title":"Sequence and comparative analysis of the genome of HSV-1 strain McKrae","volume":"433","author":"G Watson","year":"2012","journal-title":"Virology"},{"issue":"2","key":"ppat.1014566.ref047","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1128\/JVI.01987-13","article-title":"Evolution and diversity in human herpes simplex virus genomes","volume":"88","author":"ML Szpara","year":"2014","journal-title":"J Virol"},{"issue":"10","key":"ppat.1014566.ref048","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002282","article-title":"A wide extent of inter-strain diversity in virulent and vaccine strains of alphaherpesviruses","volume":"7","author":"ML Szpara","year":"2011","journal-title":"PLoS Pathog"},{"key":"ppat.1014566.ref049","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF01316752","article-title":"Immunoselection of recombinant baculoviruses expressing high levels of biologically active herpes simplex virus type 1 glycoprotein D","volume":"121","author":"H Ghiasi","year":"1991","journal-title":"Arch Virol"},{"issue":"4","key":"ppat.1014566.ref050","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1128\/jvi.68.4.2118-2126.1994","article-title":"Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice","volume":"68","author":"H Ghiasi","year":"1994","journal-title":"J Virol"},{"issue":"2","key":"ppat.1014566.ref051","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1128\/jvi.53.2.634-644.1985","article-title":"Localization of epitopes of herpes simplex virus type 1 glycoprotein D","volume":"53","author":"RJ Eisenberg","year":"1985","journal-title":"J Virol"},{"issue":"9","key":"ppat.1014566.ref052","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.1128\/JVI.72.9.7064-7074.1998","article-title":"Herpes simplex virus glycoprotein D can bind to poliovirus receptor-related protein 1 or herpesvirus entry mediator, two structurally unrelated mediators of virus entry","volume":"72","author":"C Krummenacher","year":"1998","journal-title":"J Virol"},{"issue":"8","key":"ppat.1014566.ref053","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1128\/jvi.71.8.6083-6093.1997","article-title":"Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry","volume":"71","author":"JC Whitbeck","year":"1997","journal-title":"J Virol"},{"issue":"12","key":"ppat.1014566.ref054","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.1128\/jvi.64.12.6070-6079.1990","article-title":"Glycoprotein D of herpes simplex virus encodes a domain which precludes penetration of cells expressing the glycoprotein by superinfecting herpes simplex virus","volume":"64","author":"G Campadelli-Fiume","year":"1990","journal-title":"J Virol"},{"issue":"2","key":"ppat.1014566.ref055","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/13550280590924214","article-title":"Nectin-1\/HveC mediates herpes simplex virus type 1 entry into primary human sensory neurons and fibroblasts","volume":"11","author":"SA Simpson","year":"2005","journal-title":"J Neurovirol"},{"issue":"21","key":"ppat.1014566.ref056","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.1111\/j.1742-4658.2008.06655.x","article-title":"Role for nectin-1 in herpes simplex virus 1 entry and spread in human retinal pigment epithelial cells","volume":"275","author":"V Tiwari","year":"2008","journal-title":"FEBS J"},{"issue":"34","key":"ppat.1014566.ref057","doi-asserted-by":"crossref","first-page":"12414","DOI":"10.1073\/pnas.0404211101","article-title":"Mutations in herpes simplex virus glycoprotein D that prevent cell entry via nectins and alter cell tropism","volume":"101","author":"S Manoj","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"ppat.1014566.ref058","doi-asserted-by":"crossref","first-page":"8962","DOI":"10.1128\/JVI.77.16.8962-8972.2003","article-title":"Function of herpes simplex virus type 1 gD mutants with different receptor-binding affinities in virus entry and fusion","volume":"77","author":"RSB Milne","year":"2003","journal-title":"J Virol"},{"issue":"1","key":"ppat.1014566.ref059","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085360","article-title":"Binding of HSV-1 glycoprotein K (gK) to signal peptide peptidase (SPP) is required for virus infectivity","volume":"9","author":"SJ Allen","year":"2014","journal-title":"PLoS One"},{"issue":"23","key":"ppat.1014566.ref060","doi-asserted-by":"crossref","first-page":"12962","DOI":"10.1128\/JVI.01442-07","article-title":"A recombinant herpes simplex virus type 1 expressing two additional copies of gK is more pathogenic than wild-type virus in two different strains of mice","volume":"81","author":"KR Mott","year":"2007","journal-title":"J Virol"},{"issue":"1","key":"ppat.1014566.ref061","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/viro.2002.1609","article-title":"Infection of BALB\/c mice with a herpes simplex virus type 1 recombinant virus expressing IFN-gamma driven by the LAT promoter","volume":"302","author":"H Ghiasi","year":"2002","journal-title":"Virology"},{"issue":"18","key":"ppat.1014566.ref062","doi-asserted-by":"crossref","first-page":"9069","DOI":"10.1128\/JVI.76.18.9069-9078.2002","article-title":"Overexpression of interleukin-2 by a recombinant herpes simplex virus type 1 attenuates pathogenicity and enhances antiviral immunity","volume":"76","author":"H Ghiasi","year":"2002","journal-title":"J Virol"},{"issue":"8","key":"ppat.1014566.ref063","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3390\/v17081061","article-title":"In the absence of type-1 IFN, HSV-1 LAT increases gamma34.5 expression and enhances mortality in infected mice","volume":"17","author":"JJ Oh","year":"2025","journal-title":"Viruses"},{"issue":"1","key":"ppat.1014566.ref064","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0168-1702(92)90087-P","article-title":"Expression of herpes simplex virus type 1 glycoprotein B in insect cells. Initial analysis of its biochemical and immunological properties","volume":"22","author":"H Ghiasi","year":"1992","journal-title":"Virus Res"},{"key":"ppat.1014566.ref065","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0166-3542(92)90062-A","article-title":"Baculovirus expressed herpes simplex virus type 1 glycoprotein C protects mice from lethal HSV-1 infection","volume":"18","author":"H Ghiasi","year":"1992","journal-title":"Antiviral Res"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1014566","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1014566","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:54:56Z","timestamp":1789581296000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1014566"}},"subtitle":[],"editor":[{"given":"Clinton","family":"Jones","sequence":"first","affiliation":[{"name":"Oklahoma State University College of Osteopathic Medicine","place":["UNITED STATES OF AMERICA"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":65,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1014566","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]}}}